Early Detection of Colorectal Cancer through a New Blood Test
A potential new screening tool for colorectal cancer may soon be available pending FDA approval. This innovative blood test, developed by Guardant Health, aims to detect colorectal cancer through a simple blood draw. The test has shown promising results, detecting 83% of individuals with colorectal cancer in a recent clinical trial published in The New England Journal of Medicine.
Dr. Barbara Jung, president of the American Gastroenterological Association, believes that this blood test could significantly enhance the early detection of colorectal cancer. She emphasizes the importance of reaching more individuals through non-invasive screening methods to improve overall detection rates.
While the blood test offers a less invasive alternative to traditional screening methods, such as colonoscopies, it is not intended to replace them entirely. Dr. Jung stresses that a positive result from the blood test would necessitate a follow-up colonoscopy, as it remains the gold standard for detecting precancerous polyps and preventing cancer development.
Despite the availability of effective screening options like stool tests and colonoscopies, a significant portion of the population remains unscreened for colorectal cancer. Guardant Health’s CEO, AmirAli Talasaz, highlights the need for more convenient and accessible screening methods to encourage greater compliance with recommended screening guidelines.
Colorectal cancer, once considered a disease of older adults, is increasingly being diagnosed in younger individuals. The rise in cases among individuals under 50 underscores the importance of early detection and proactive screening measures. Guardant Health’s pending FDA approval for the blood test represents a significant step towards improving colorectal cancer screening and detection rates.
If you notice any symptoms such as blood in your stool, changes in bowel habits, unexplained weight loss, bloating, or fatigue, it is crucial to consult your healthcare provider promptly. Early detection and timely intervention are key in effectively managing colorectal cancer.
As the landscape of colorectal cancer diagnosis evolves, embracing innovative screening technologies like the blood test from Guardant Health can potentially revolutionize early detection efforts. Stay informed about the latest advancements in colorectal cancer screening to prioritize your health and well-being.
This story was edited by Jane Greenhalgh
For more information on colorectal cancer early detection, please visit our site 60time.com. Don’t forget to follow us on social media at Facebook.
